73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Health Disparities Persist in Hemophilia Life Expectancy

Health Disparities Persist in Hemophilia Life Expectancy

January 2024Lara C. Pullen, PhDBetween 1999 and 2020, recorded hemophilia death (rHD) rates in the U.S. improved in males across all racial and ethnic groups.Stacey A. Fedewa, PhD, MPH,of

Health Disparities Persist in Hemophilia Life Expectancy

January 2024Lara C. Pullen, PhDBetween 1999 and 2020, recorded hemophilia death (rHD) rates in the U.S. improved in males across all racial and ethnic groups.Stacey A. Fedewa, PhD, MPH,of
Surgery may add months or years of survival for adults with rare and deadly brain cancers

Surgery may add months or years of survival for adults with rare and deadly brain cancers

by Amy Mone,Johns Hopkins UniversityCredit: Alicia Ortega, MSFor adult patients with brainstem high-grade gliomas—one of the rarest and deadliest forms of brain cancer—surgically removing the en

Surgery may add months or years of survival for adults with rare and deadly brain cancers

by Amy Mone,Johns Hopkins UniversityCredit: Alicia Ortega, MSFor adult patients with brainstem high-grade gliomas—one of the rarest and deadliest forms of brain cancer—surgically removing the en
Endoscopic approaches feasible in surgery for sinonasal cancer

Endoscopic approaches feasible in surgery for sinonasal cancer

(HealthDay)—Endoscopic approaches are feasible for the surgical resection of sinonasal cancer, according to a study published online Dec. 24 inHead & Neck.Ahmed S. Abdelmeguid, M.D., Ph.D.,

Endoscopic approaches feasible in surgery for sinonasal cancer

(HealthDay)—Endoscopic approaches are feasible for the surgical resection of sinonasal cancer, according to a study published online Dec. 24 inHead & Neck.Ahmed S. Abdelmeguid, M.D., Ph.D.,
CAR T cell therapy for T cell lymphoma shows promise in phase I trial

CAR T cell therapy for T cell lymphoma shows promise in phase I trial

by Molly Chiu,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital, and Hou

CAR T cell therapy for T cell lymphoma shows promise in phase I trial

by Molly Chiu,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital, and Hou
Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

by Garth Sundem,CU Anschutz Medical CampusRobert C. Doebele, MD, PhD. Credit: CU Anschutz Medical CampusPooled analysis of three phase 1 and 2 clinical trials published online ahead of print in

Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

by Garth Sundem,CU Anschutz Medical CampusRobert C. Doebele, MD, PhD. Credit: CU Anschutz Medical CampusPooled analysis of three phase 1 and 2 clinical trials published online ahead of print in
IBIS-II study finds anastrozole reduces breast cancer rates for high risk postmenopausal women

IBIS-II study finds anastrozole reduces breast cancer rates for high risk postmenopausal women

byQueen Mary, University of LondonCredit: CC0 Public DomainThe Queen Mary University of London professor leading an international breast cancer study says anastrozole—rather than tamoxifen—shoul

IBIS-II study finds anastrozole reduces breast cancer rates for high risk postmenopausal women

byQueen Mary, University of LondonCredit: CC0 Public DomainThe Queen Mary University of London professor leading an international breast cancer study says anastrozole—rather than tamoxifen—shoul
Reprogramming cancer cells into immune defenders

Reprogramming cancer cells into immune defenders

by Tove Smeds,Lund UniversityDolly the sheep determined Filipe Pereira’s future career. The choice was between becoming an architect or a scientist, when one of the world’s most extreme examples

Reprogramming cancer cells into immune defenders

by Tove Smeds,Lund UniversityDolly the sheep determined Filipe Pereira’s future career. The choice was between becoming an architect or a scientist, when one of the world’s most extreme examples
Scientists identify a gene signature to assess cancer risk in people

Scientists identify a gene signature to assess cancer risk in people

byThe Wistar InstituteWistar's Dr. Maureen Murphy and lab. Credit: The Wistar InstituteIn a paper published inPNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ron

Scientists identify a gene signature to assess cancer risk in people

byThe Wistar InstituteWistar's Dr. Maureen Murphy and lab. Credit: The Wistar InstituteIn a paper published inPNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ron
Researchers design new hydrogel for more targeted cancer treatments

Researchers design new hydrogel for more targeted cancer treatments

by Safa Jinje,University of TorontoGraphical abstract. Credit:Materials Today(2022). DOI: 10.1016/j.mattod.2022.01.023University of Toronto researchers have designed a new way to gro

Researchers design new hydrogel for more targeted cancer treatments

by Safa Jinje,University of TorontoGraphical abstract. Credit:Materials Today(2022). DOI: 10.1016/j.mattod.2022.01.023University of Toronto researchers have designed a new way to gro
Despite misperceptions, hormone therapy may actually reduce risk of lung cancer

Despite misperceptions, hormone therapy may actually reduce risk of lung cancer

by Teddy RosenbluthCredit: Unsplash/CC0 Public DomainAfter six years of painful injections, Stephanie Walker has had enough.Every 28 days, she drives an hour to Duke's Cancer center to get 50 mL s

Despite misperceptions, hormone therapy may actually reduce risk of lung cancer

by Teddy RosenbluthCredit: Unsplash/CC0 Public DomainAfter six years of painful injections, Stephanie Walker has had enough.Every 28 days, she drives an hour to Duke's Cancer center to get 50 mL s
Five facts you may not know about brain tumors

Five facts you may not know about brain tumors

by Laura Hegwer,Rush University Medical CenterCredit: Unsplash/CC0 Public DomainBrain tumors scare most people, but there are still reasons to be hopeful if you learn you have an abnormal growth

Five facts you may not know about brain tumors

by Laura Hegwer,Rush University Medical CenterCredit: Unsplash/CC0 Public DomainBrain tumors scare most people, but there are still reasons to be hopeful if you learn you have an abnormal growth
World-first treatment with 'acoustic cluster therapy' to improve chemotherapy delivery

World-first treatment with 'acoustic cluster therapy' to improve chemotherapy delivery

byInstitute of Cancer ResearchCredit: CC0 Public DomainThe first patient has been treated with an innovative new technology that uses microscopic clusters of bubbles and liquid droplets to enhan

World-first treatment with 'acoustic cluster therapy' to improve chemotherapy delivery

byInstitute of Cancer ResearchCredit: CC0 Public DomainThe first patient has been treated with an innovative new technology that uses microscopic clusters of bubbles and liquid droplets to enhan